Incannex Healthcare vs Lexaria Bioscience
IXHL and LEXX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IXHL and LEXX compare
Lexaria Bioscience is the larger company, worth 4.5 times as much as Incannex Healthcare ($110M against $24.7M).
Lexaria Bioscience scores higher on the StockData Score (8 against 7 for Incannex Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IXHL | LEXX |
|---|---|---|
| Size and price | ||
| Market cap | $24.7M | $110M |
| Share price | $1.97 | $4.44 |
| Change, 1 year | −82.4% | −74.0% |
| Change, 5 years | – | −94.7% |
| Beta (5Y) | 1.95 | 0.82 |
| Employees | 12 | 134 |
| StockData Score | ||
| Total score | 7 | 8 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 1 (better) | 0 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 567× |
| P/B | 0.4× (better) | 23.2× |
| FCF yield | −52.1% | −6.8% (better) |
| Growth | ||
| Revenue growth (TTM) | – | −68.5% |
| Revenue growth, 5Y average | – | 17.5% |
| Profitability | ||
| Gross margin | – | 100% |
| Operating margin | – | −3973% |
| Net margin | – | −3986% |
| FCF margin | – | −3849% |
| Return on equity | −47.8% (better) | −150% |
| Return on invested capital | – | −602% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 48.81 (better) | 10.60 |
| Altman Z-score | −0.62 | 126.66 (better) |
| Piotroski F-score | 4 (better) | 2 |
| Dividends and buybacks | ||
| Buyback yield | −280% | −5.9% (better) |
| Shareholder yield | −280% | −5.9% (better) |
| Ownership | ||
| Held by institutions | 3.6% | – |
| Held by insiders | – | 3.0% |
| Short interest, % of float | – | 0.90% |
Go deeper
- IXHL stock overview
- IXHL income statement
- IXHL valuation and score
- LEXX stock overview
- LEXX income statement
- LEXX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.